Skip to main content
SpringerLink
Log in

Eptacog alfa cost effective for bleeding control in trauma care?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Morris S, Ridley S, Munro V, Christensen MC, NovoSeven (Rm) Trauma Study Group.Cost effectiveness of recombinant activated factor VII for the control of bleeding in patients with severe blunt trauma injuries in the United Kingdom. Anaesthesia 62: 43-52, No. 1, 1 Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eptacog alfa cost effective for bleeding control in trauma care?. Pharmacoecon. Outcomes News 524, 9 (2007). https://doi.org/10.2165/00151234-200705240-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705240-00018

Keywords

Search

Navigation